From the commencement of my doctoral research, my core academic focus has centered on dissecting the cellular signalling networks governing eukaryotic protein synthesis. My systematic research programmes have delivered pivotal insights that advance our understanding of how mRNA translation coupled with signal transduction drives the onset and progression of prevalent human diseases, notably prostate and colorectal cancers, as well as metabolic disorders including diabetes. Beyond clinical pathology exploration, my work also translates fundamental molecular mechanisms into practical strategies for small-molecule anticancer drug discovery and industrial recombinant protein manufacturing. To date, I have published a total of 55 peer-reviewed scientific articles. Among these, 25 are first or corresponding author contributions featured in high-impact international journals, such as PNAS, Nature Cell Biology, Current Biology, Diabetologia, Oncogene and Cellular & Molecular Life Sciences. As of June 4, 2026, my cumulative Google Scholar citation count exceeds 3,200, with an h-index of 32. My academic output further encompasses six authorized invention patents and four authoritative book chapters published by world-renowned academic publishers including Springer Nature and Elsevier. I have also delivered eight invited oral presentations at prestigious international symposia dedicated to mRNA translation and oncology.